Rpharmy Honored With Family Business Award From Austin Business Journal
Austin-Based Healthcare Technology Provider Recognized for Community Impact, Life-Saving Solutions that Protect…
12,000 Students from 15 Nations Celebrate Ryan Group’s Golden Jubilee in Mumbai
MUMBAI, India, Dec. 13, 2025 /PRNewswire/ -- Mumbai's Fine Arts Centre, came…
From ‘Make in India’ to ‘Design for India’: Ajay Piramal Charts a Vision for Nation-Building at Anant National University
AHMEDABAD, India, Dec. 12, 2025 /PRNewswire/ -- Anant National University celebrated its…
IOC receives Low Carbon Award from Geneva climate network 2050Today
11 december 2025 - In recognition of its progress in reducing its…
Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility
December 10, 2025 04:00 ET | Source: Igyxos TOURS, France, Dec. 10,…
From the Capital of Capital, ADFW Charts the Next Frontier in Asset Management
ABU DHABI, UAE, Dec. 9, 2025 /PRNewswire/ -- Abu Dhabi Finance Week…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…
Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition
93% overall response and 76% complete response rates with median progression-free survival…
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
December 07, 2025 16:00 ET | Source: Wave Life Sciences USA, Inc.…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm…
